Physician
Obstetrics & Gynecology
Dr. Nicholas A. Cataldo, MD
|
|
Give Review
Nicholas Cataldo practices Obstetrics & Gynecology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care Nicholas Cataldo is a published doctor and has 33 publications published. The lastest was: 'Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and -4 accumulation by human luteinizing granulosa cells, and interferon-gamma prom...'
Publications
- Smoking in infertile women with polycystic ovary syndrome: baseline validation of self-report and effects on phenotype.
- Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone.
- Immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome: relationship to apoptosis.
- The insulin-related ovarian regulatory system in health and disease.
- Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and -4 accumulation by human luteinizing granulosa cells, and interferon-gamma prom...
- Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome?
- Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-co...
- Growth factors in normal ovarian follicle development.
- Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome.
- Apoptosis in the human female reproductive tract.
- Comparison of functional response of rat, macaque, and human ovarian cells in hormonally defined medium.
- The potential roles of intraovarian peptides in normal and abnormal mechanisms of reproductive physiology.
- Regulation of insulin-like growth factor binding protein production by human luteinizing granulosa cells cultured in defined medium.
- Activin-A stimulates the expression of insulin-like growth factor binding protein-5 messenger RNA in human luteinizing granulosa cells.
- Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells.
- The effect of thyroid hormones on prolactin secretion by cultured bovine pituitary cells.
- Uterine serosal trophoblastic implant after linear salpingostomy for ectopic pregnancy at laparotomy.
- Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status.
- Follicular fluid insulin-like growth factor binding protein profiles in polycystic ovary syndrome.
- Ovarian pregnancy in polycystic ovary syndrome: a case report.
- The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study.
- Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome.
- Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.
- Body mass index and intercourse compliance.
- Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network''s Pregnancy in ...
- Predictors of pregnancy in women with polycystic ovary syndrome.
- Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome.
- Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network''s Pregnancy in Polycystic Ova...
- Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.
- Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.
- The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.
- Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
Schools
Harvard Medical School
Conditions Treated
- Perimenopause
- Symptomatic Menopause
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Education
-
Stanford University -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Warner K. Huh, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jacob M. Estes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet A. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian M. Dey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce A. Julien, MD
This Doctor is OpenDoctor Recommended.
|